CVS Health

CVS

Market cap $137B

CVS Hedge Fund Activity: Q1 2026 in Review

1,866 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2026, worth a combined $79.3B — down 12% from $89.8B a quarter earlier.

Sellers outnumbered buyers: 196 funds closed out of CVS and 155 opened new positions — a net loss of 41 holders — while 745 trimmed existing stakes and 722 added.

The largest buyer was Capital World Investors, adding an estimated $738M. The largest seller was Capital International Investors, cutting an estimated $940M.

• 1,866 institutional investors held CVS Health (CVS) as of Q1 2026, down from 1,945 in Q4 2025.
• Funds reported $79.3B of CVS Health stock for Q1 2026, down 12% quarter-over-quarter.
• 155 funds opened new CVS Health positions in Q1 2026 and 196 closed out, a net change of -41 holders.
• The largest CVS Health buyer in Q1 2026 was Capital World Investors, an estimated $738M added.
• The largest CVS Health seller in Q1 2026 was Capital International Investors, an estimated $940M sold.

Based on aggregated 13F filings for Q1 2026.